NKARTA INC's ticker is NKTX and the CUSIP is 65487U108. A total of 90 filers reported holding NKARTA INC in Q2 2021. The put-call ratio across all filers is 5.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,986,569 | -36.5% | 2,868,035 | 0.0% | 1.22% | +10.7% |
| Q2 2023 | $6,280,997 | -38.3% | 2,868,035 | 0.0% | 1.10% | -47.6% |
| Q1 2023 | $10,181,524 | -40.7% | 2,868,035 | 0.0% | 2.10% | -43.1% |
| Q4 2022 | $17,179,530 | -54.5% | 2,868,035 | 0.0% | 3.70% | -58.0% |
| Q3 2022 | $37,743,000 | +6.8% | 2,868,035 | 0.0% | 8.80% | -6.6% |
| Q2 2022 | $35,334,000 | +52.6% | 2,868,035 | +41.0% | 9.42% | +61.6% |
| Q1 2022 | $23,155,000 | -25.9% | 2,034,702 | -0.0% | 5.83% | -3.8% |
| Q4 2021 | $31,233,000 | -44.8% | 2,034,703 | 0.0% | 6.06% | -31.8% |
| Q3 2021 | $56,585,000 | -12.2% | 2,034,703 | 0.0% | 8.88% | +11.5% |
| Q2 2021 | $64,480,000 | -3.7% | 2,034,703 | 0.0% | 7.96% | -35.5% |
| Q1 2021 | $66,942,000 | -46.5% | 2,034,703 | 0.0% | 12.35% | -1.8% |
| Q4 2020 | $125,073,000 | +104.5% | 2,034,703 | 0.0% | 12.58% | -26.3% |
| Q3 2020 | $61,163,000 | – | 2,034,703 | – | 17.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,703 | $31,233,000 | 6.06% |
| Novo Holdings A/S | 2,793,864 | $42,886,000 | 2.03% |
| RA Capital Management | 5,605,129 | $86,039,000 | 1.52% |
| Deep Track Capital, LP | 1,264,426 | $19,409,000 | 1.37% |
| NEA Management Company, LLC | 2,904,974 | $44,591,000 | 0.90% |
| Vivo Capital, LLC | 512,225 | $7,863,000 | 0.47% |
| Pinz Capital Management, LP | 40,000 | $614,000 | 0.24% |
| Rock Springs Capital Management LP | 507,248 | $7,786,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,200 | $617,000 | 0.14% |
| EMC Capital Management | 12,548 | $193,000 | 0.10% |